October 21, 2008 — Clinicians should receive specialized training for the transvaginal placement of mesh products and be vigilant for adverse events, the US Food and Drug Administration (FDA) warned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback